PHARMACEUTICAL PRODUCT DEVELOPMENT INC Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31)
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) of $1.00 million for the 3-month period ending 2011-09-30, per its 10-Q filed 2011-11-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpense · last filed 2011-11-02
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2011-09-30 was $1.00M, a 11.11% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2011-06-30 was $1.00M, a 11.11% increase year-over-year.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2010-09-30 was $900.00K.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC finite-lived intangible assets, amortization expense (deprecated 2012-01-31) for the quarter ending 2010-06-30 was $900.00K.
| Period end | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 3 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 6 month | Finite-Lived Intangible Assets, Amortization Expense (Deprecated 2012-01-31) 9 month |
|---|---|---|---|
| 2011-09-30 | $1.00M 10-Q · filed 2011-11-02 | $2.00M derived: sum of 2 quarters · filed 2011-11-02 | $3.00M 10-Q · filed 2011-11-02 |
| 2011-06-30 | $1.00M 10-Q · filed 2011-08-04 | $2.00M 10-Q · filed 2011-08-04 | |
| 2010-09-30 | $900.00K 10-Q · filed 2011-11-02 | $1.80M derived: sum of 2 quarters · filed 2011-11-02 | $2.80M 10-Q · filed 2011-11-02 |
| 2010-06-30 | $900.00K 10-Q · filed 2011-08-04 | $1.90M 10-Q · filed 2011-08-04 |